Trials / Completed
CompletedNCT00322621
Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
Maintenance of Effect of Duloxetine 60 mg Once Daily in Patients With Diabetic Peripheral Neuropathic Pain
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 216 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine if duloxetine 60 mg once daily can work up to 6 months in treating pain from Diabetic Neuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2007-10-01
- Completion
- 2007-10-01
- First posted
- 2006-05-08
- Last updated
- 2011-02-07
- Results posted
- 2009-12-18
Locations
19 sites across 4 countries: Brazil, France, Germany, Italy
Source: ClinicalTrials.gov record NCT00322621. Inclusion in this directory is not an endorsement.